Detalhe da pesquisa
1.
SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID-19: The International Study of Inflammation in COVID-19.
J Med Virol
; 96(1): e29389, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38235904
2.
Transepidermal water loss rises before food anaphylaxis and predicts food challenge outcomes.
J Clin Invest
; 133(16)2023 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37402149
3.
Differences in Inflammation, Treatment, and Outcomes Between Black and Non-Black Patients Hospitalized for COVID-19: A Prospective Cohort Study.
Am J Med
; 135(3): 360-368, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34793753
4.
Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19.
Diabetes Care
; 45(3): 692-700, 2022 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35045184
5.
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19.
J Am Heart Assoc
; 11(18): e025198, 2022 09 20.
Artigo
Inglês
| MEDLINE | ID: mdl-35924778
6.
Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis.
J Clin Invest
; 132(24)2022 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36194491
7.
Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19.
J Clin Med
; 10(17)2021 Aug 30.
Artigo
Inglês
| MEDLINE | ID: mdl-34501358